Unichem Laboratories receives ANDA approval for Extended Phenytoin Sodium Capsules

Unichem Laboratories Limited has received ANDA approval for its Extended Phenytoin Sodium Capsules USP, 100 mg from the United States Food and Drug Administration (USFDA) to market a generic version of Dilantin® (Phenytoin Sodium) Capsules, 100 mg, of Viatris Specialty LLC.

Extended Phenytoin Sodium Capsules are indicated for the treatment of tonic-clonic (grand mal) and psychomotor (temporal lobe) seizures and prevention and treatment of seizures occurring during or following neurosurgery. The product will be commercialized from Unichem's Ghaziabad Plant.

Shares of Unichem Laboratories Limited was last trading in BSE at Rs. 360.95 as compared to the previous close of Rs. 364.25. The total number of shares traded during the day was 14582 in over 787 trades.

The stock hit an intraday high of Rs. 367.40 and intraday low of 357.10. The net turnover during the day was Rs. 5279418.00.

Source : Equity Bulls

Keywords

UnichemLaboratories INE351A01035 ANDAApproval USFDA ExtendedPhenytoinSodiumCapsules